Seminars in Oncology
Volume 33, Issue 2 , Pages 157-166 , April 2006

Epigenetics in Chronic Lymphocytic Leukemia

  • Aparna Raval

      Affiliations

    • Department of Molecular Virology, Immunology, and Medical Genetics, Division of Human Cancer Genetics, The Ohio State University, Columbus, OH.
    • ,
  • John C. Byrd

      Affiliations

    • Division of Hematology-Oncology, Department of Medicine, The Ohio State University, Columbus, OH.
    • ,
  • Christoph Plass

      Affiliations

    • Department of Molecular Virology, Immunology, and Medical Genetics, Division of Human Cancer Genetics, The Ohio State University, Columbus, OH.
    • Corresponding Author InformationAddress correspondence to Christoph Plass, Professor, Division of Human Cancer Genetics, Tzagournis Medical Research Facility 474A, 420 W 12th Ave, The Ohio State University, Columbus, OH 43210.

References 

  1. Wolffe AP , Guschin D . Review (Chromatin structural features and targets that regulate transcription) . J Struct Biol . 2000;129:102–122
  2. Lee PP , Fitzpatrick DR , Beard C , et al.   A critical role for Dnmt1 and DNA methylation in T cell development, function, and survival . Immunity . 2001;15:763–774
  3. Esteller M , Fraga MF , Guo M , et al.   DNA methylation patterns in hereditary human cancers mimic sporadic tumorigenesis . Hum Mol Genet . 2001;10:3001–3007
  4. Myohanen SK , Baylin SB , Herman JG . Hypermethylation can selectively silence individual p16ink4A alleles in neoplasia . Cancer Res . 1998;58:591–593
  5. Ioshikhes IP , Zhang MQ . Large-scale human promoter mapping using CpG islands . Nat Genet . 2000;26:61–63
  6. Takai D , Jones PA . Comprehensive analysis of CpG islands in human chromosomes 21 and 22 . Proc Natl Acad Sci U S A . 2002;99:3740–3745
  7. Yoder JA , Walsh CP , Bestor TH . Cytosine methylation and the ecology of intragenomic parasites . Trends Genet . 1997;13:335–340
  8. Pfeifer GP , Tanguay RL , Steigerwald SD , et al.   In vivo footprint and methylation analysis by PCR-aided genomic sequencing (Comparison of active and inactive X chromosomal DNA at the CpG island and promoter of human PGK-1) . Genes Dev . 1990;4:1277–1287
  9. Csankovszki G , Nagy A , Jaenisch R . Synergism of Xist RNA, DNA methylation, and histone hypoacetylation in maintaining X chromosome inactivation . J Cell Biol . 2001;153:773–784
  10. Li E , Beard C , Jaenisch R . Role for DNA methylation in genomic imprinting . Nature . 1993;366:362–365
  11. Ching TT , Maunakea AK , Jun P , et al.   Epigenome analyses using BAC microarrays identify evolutionary conservation of tissue-specific methylation of SHANK3 . Nat Genet . 2005;37:645–651
  12. Li E , Bestor TH , Jaenisch R . Targeted mutation of the DNA methyltransferase gene results in embryonic lethality . Cell . 1992;69:915–926
  13. Okano M , Bell DW , Haber DA , et al.   DNA methyltransferases Dnmt3a and Dnmt3b are essential for de novo methylation and mammalian development . Cell . 1999;99:247–257
  14. Chuang LS , Ian HI , Koh TW , et al.   Human DNA-(cytosine-5) methyltransferase-PCNA complex as a target for p21WAF1 . Science . 1997;277:1996–2000
  15. Rhee I , Jair KW , Yen RW , et al.   CpG methylation is maintained in human cancer cells lacking DNMT1 . Nature . 2000;404:1003–1007
  16. Rhee I , Bachman KE , Park BH , et al.   DNMT1 and DNMT3b cooperate to silence genes in human cancer cells . Nature . 2002;416:552–556
  17. Liang G , Chan MF , Tomigahara Y , et al.   Cooperativity between DNA methyltransferases in the maintenance methylation of repetitive elements . Mol Cell Biol . 2002;22:480–491
  18. He H , Lehming N . Global effects of histone modifications . Brief Funct Genomic Proteomic . 2003;2:234–243
  19. Annunziato AT , Hansen JC . Role of histone acetylation in the assembly and modulation of chromatin structures . Gene Expr . 2000;9:37–61
  20. Jenuwein T , Allis CD . Translating the histone code . Science . 2001;293:1074–1080
  21. Legube G , Trouche D . Regulating histone acetyltransferases and deacetylases . EMBO Rep . 2003;4:944–947
  22. Sterner DE , Berger SL . Acetylation of histones and transcription-related factors . Microbiol Mol Biol Rev . 2000;64:435–459
  23. Kuzmichev A , Reinberg D . Role of histone deacetylase complexes in the regulation of chromatin metabolism . Curr Top Microbiol Immunol . 2001;254:35–58
  24. Ito A , Lai CH , Zhao X , et al.   p300/CBP-mediated p53 acetylation is commonly induced by p53-activating agents and inhibited by MDM2 . EMBO J . 2001;20:1331–1340
  25. Jin YH , Jeon EJ , Li QL , et al.   Transforming growth factor-beta stimulates p300-dependent RUNX3 acetylation, which inhibits ubiquitination-mediated degradation . J Biol Chem . 2004;279:29409–29417
  26. Santos-Rosa H , Schneider R , Bannister AJ , et al.   Active genes are tri-methylated at K4 of histone H3 . Nature . 2002;419:407–411
  27. Noma K , Allis CD , Grewal SI . Transitions in distinct histone H3 methylation patterns at the heterochromatin domain boundaries . Science . 2001;293:1150–1155
  28. Cao R , Wang L , Wang H , et al.   Role of histone H3 lysine 27 methylation in Polycomb-group silencing . Science . 2002;298:1039–1043
  29. Zhang Y , Reinberg D . Transcription regulation by histone methylation (interplay between different covalent modifications of the core histone tails) . Genes Dev . 2001;15:2343–2360
  30. Feng Q , Wang H , Ng HH , et al.   Methylation of H3-lysine 79 is mediated by a new family of HMTases without a SET domain . Curr Biol . 2002;12:1052–1058
  31. Peterson CL , Laniel MA . Histones and histone modifications . Curr Biol . 2004;14:R546–R551
  32. Hall IM , Shankaranarayana GD , Noma K , et al.   Establishment and maintenance of a heterochromatin domain . Science . 2002;297:2232–2237
  33. Feinberg AP , Vogelstein B . Hypomethylation distinguishes genes of some human cancers from their normal counterparts . Nature . 1983;301:89–92
  34. Feinberg AP , Vogelstein B . Hypomethylation of ras oncogenes in primary human cancers . Biochem Biophys Res Commun . 1983;111:47–54
  35. Hanada M , Delia D , Aiello A , et al.   bcl-2 gene hypomethylation and high-level expression in B-cell chronic lymphocytic leukemia . Blood . 1993;82:1820–1828
  36. Qu GZ , Grundy PE , Narayan A , et al.   Frequent hypomethylation in Wilms tumors of pericentromeric DNA in chromosomes 1 and 16 . Cancer Genet Cytogenet . 1999;109:34–39
  37. Xu GL , Bestor TH , Bourc’his D , et al.   Chromosome instability and immunodeficiency syndrome caused by mutations in a DNA methyltransferase gene . Nature . 1999;402:187–191
  38. Gaudet F , Hodgson JG , Eden A , et al.   Induction of tumors in mice by genomic hypomethylation . Science . 2003;300:489–492
  39. Costello JF , Fruhwald MC , Smiraglia DJ , et al.   Aberrant CpG-island methylation has non-random and tumour-type-specific patterns . Nat Genet . 2000;24:132–138
  40. Garcia MJ , Martinez-Delgado B , Cebrian A , et al.   Different incidence and pattern of p15INK4b and p16INK4a promoter region hypermethylation in Hodgkin’s and CD30-Positive non-Hodgkin’s lymphomas . Am J Pathol . 2002;161:1007–1013
  41. Di Croce L , Raker VA , Corsaro M , et al.   Methyltransferase recruitment and DNA hypermethylation of target promoters by an oncogenic transcription factor . Science . 2002;295:1079–1082
  42. Galm O , Wilop S , Reichelt J , et al.   DNA methylation changes in multiple myeloma . Leukemia . 2004;18:1687–1692
  43. Roman-Gomez J , Jimenez-Velasco A , Castillejo JA , et al.   Promoter hypermethylation of cancer-related genes (A strong independent prognostic factor in acute lymphoblastic leukemia) . Blood . 2004;104:2492–2498
  44. Roman-Gomez J , Castillejo JA , Jimenez A , et al.   Cadherin-13, a mediator of calcium-dependent cell-cell adhesion, is silenced by methylation in chronic myeloid leukemia and correlates with pretreatment risk profile and cytogenetic response to interferon alfa . J Clin Oncol . 2003;21:1472–1479
  45. Baker EK , El-Osta A . The rise of DNA methylation and the importance of chromatin on multidrug resistance in cancer . Exp Cell Res . 2003;290:177–194
  46. Rush LJ , Dai Z , Smiraglia DJ , et al.   Novel methylation targets in de novo acute myeloid leukemia with prevalence of chromosome 11 loci . Blood . 2001;97:3226–3233
  47. Caligiuri MA , Strout MP , Schichman SA , et al.   Partial tandem duplication of ALL1 as a recurrent molecular defect in acute myeloid leukemia with trisomy 11 . Cancer Res . 1996;56:1418–1425
  48. Lin SF , Lin PM , Liu TC , et al.   Clinical implications of aberrant TSG101 transcripts in acute myeloblastic leukemia . Leuk Lymphoma . 2000;36:463–466
  49. Schaffner C , Idler I , Stilgenbauer S , et al.   Mantle cell lymphoma is characterized by inactivation of the ATM gene . Proc Natl Acad Sci U S A . 2000;97:2773–2778
  50. Herman JG , Civin CI , Issa JP , et al.   Distinct patterns of inactivation of p15INK4B and p16INK4A characterize the major types of hematological malignancies . Cancer Res . 1997;57:837–841
  51. Herman JG , Jen J , Merlo A , et al.   Hypermethylation-associated inactivation indicates a tumor suppressor role for p15INK4B . Cancer Res . 1996;56:722–727
  52. Yu L , Liu C , Vandeusen J , et al.   Global assessment of promoter methylation in a mouse model of cancer identifies ID4 as a putative tumor-suppressor gene in human leukemia . Nat Genet . 2005;37:265–274
  53. Racanicchi S , Maccherani C , Liberatore C , et al.   Targeting fusion protein/corepressor contact restores differentiation response in leukemia cells . EMBO J . 2005;24:1232–1242
  54. Okada Y , Feng Q , Lin Y , et al.   hDOT1L links histone methylation to leukemogenesis . Cell . 2005;121:167–178
  55. Jones PL , Veenstra GJ , Wade PA , et al.   Methylated DNA and MeCP2 recruit histone deacetylase to repress transcription . Nat Genet . 1998;19:187–191
  56. Nan X , Ng HH , Johnson CA , et al.   Transcriptional repression by the methyl-CpG-binding protein MeCP2 involves a histone deacetylase complex . Nature . 1998;393:386–389
  57. Jones PL , Wade PA , Wolffe AP . Purification of the MeCP2/histone deacetylase complex from Xenopus laevis . Methods Mol Biol . 2001;181:297–307
  58. Fuks F , Hurd PJ , Deplus R , et al.   The DNA methyltransferases associate with HP1 and the SUV39H1 histone methyltransferase . Nucleic Acids Res . 2003;31:2305–2312
  59. Shaker S , Bernstein M , Momparler LF , et al.   Preclinical evaluation of antineoplastic activity of inhibitors of DNA methylation (5-aza-2′-deoxycytidine) and histone deacetylation (trichostatin A, depsipeptide) in combination against myeloid leukemic cells . Leuk Res . 2003;27:437–444
  60. Bachman KE , Park BH , Rhee I , et al.   Histone modifications and silencing prior to DNA methylation of a tumor suppressor gene . Cancer Cell . 2003;3:89–95
  61. Leu YW , Yan PS , Fan M , et al.   Loss of estrogen receptor signaling triggers epigenetic silencing of downstream targets in breast cancer . Cancer Res . 2004;64:8184–8192
  62. Stirzaker C , Song JZ , Davidson B , et al.   Transcriptional gene silencing promotes DNA hypermethylation through a sequential change in chromatin modifications in cancer cells . Cancer Res . 2004;64:3871–3877
  63. Cameron EE , Bachman KE , Myohanen S , et al.   Synergy of demethylation and histone deacetylase inhibition in the re-expression of genes silenced in cancer . Nat Genet . 1999;21:103–107
  64. Belinsky SA , Klinge DM , Stidley CA , et al.   Inhibition of DNA methylation and histone deacetylation prevents murine lung cancer . Cancer Res . 2003;63:7089–7093
  65. Dohner H , Stilgenbauer S , Benner A , et al.   Genomic aberrations and survival in chronic lymphocytic leukemia . N Engl J Med . 2000;343:1910–1916
  66. Jewell AP . Role of apoptosis in the pathogenesis of B-cell chronic lymphocytic leukaemia . Br J Biomed Sci . 2002;59:235–238
  67. Lin K , Manocha S , Harris RJ , et al.   High frequency of p53 dysfunction and low level of VH mutation in chronic lymphocytic leukemia patients using the VH3-21 gene segment . Blood . 2003;102:1145–1146
  68. Stankovic T , Stewart GS , Fegan C , et al.   Ataxia telangiectasia mutated-deficient B-cell chronic lymphocytic leukemia occurs in pregerminal center cells and results in defective damage response and unrepaired chromosome damage . Blood . 2002;9:300–309
  69. Calin GA , Dumitru CD , Shimizu M , et al.   Frequent deletions and down-regulation of micro- RNA genes miR15 and miR16 at 13q14 in chronic lymphocytic leukemia . Proc Natl Acad Sci U S A . 2002;99:15524–15529
  70. Wahlfors J , Hiltunen H , Heinonen K , et al.   Genomic hypomethylation in human chronic lymphocytic leukemia . Blood . 1992;80:2074–2080
  71. de Capoa A , Grappelli C , Febbo FR , et al.   Methylation levels of normal and chronic lymphocytic leukemia B lymphocytes (computer-assisted quantitative analysis of anti-5-methylcytosine antibody binding to individual nuclei) . Cytometry . 1999;36:157–159
  72. Eden A , Gaudet F , Waghmare A , et al.   Chromosomal instability and tumors promoted by DNA hypomethylation . Science . 2003;300:455
  73. Kantharidis P , El-Osta A , deSilva M , et al.   Altered methylation of the human MDR1 promoter is associated with acquired multidrug resistance . Clin Cancer Res . 1997;3:2025–2032
  74. Yuille MR , Condie A , Stone EM , et al.   TCL1 is activated by chromosomal rearrangement or by hypomethylation . Genes Chromosomes Cancer . 2001;30:336–341
  75. Pekarsky Y , Hallas C , Croce CM . The role of TCL1 in human T-cell leukemia . Oncogene . 2001;20:5638–5643
  76. Bichi R , Shinton SA , Martin ES , et al.   Human chronic lymphocytic leukemia modeled in mouse by targeted TCL1 expression . Proc Natl Acad Sci U S A . 2002;99:6955–6960
  77. Fulop Z , Csernus B , Timar B , et al.   Microsatellite instability and hMLH1 promoter hypermethylation in Richter’s transformation of chronic lymphocytic leukemia . Leukemia . 2003;17:411–415
  78. Melki JR , Vincent PC , Brown RD , et al.   Hypermethylation of E-cadherin in leukemia . Blood . 2000;95:3208–3213
  79. Armeanu S , Buhring HJ , Reuss-Borst M , et al.   E-cadherin is functionally involved in the maturation of the erythroid lineage . J Cell Biol . 1995;131:243–249
  80. Bechter OE , Eisterer W , Dlaska M , et al.   CpG island methylation of the hTERT promoter is associated with lower telomerase activity in B-cell lymphocytic leukemia . Exp Hematol . 2002;30:26–33
  81. Rush LJ , Raval A , Funchain P , et al.   Epigenetic profiling in chronic lymphocytic leukemia reveals novel methylation targets . Cancer Res . 2004;64:2424–2433
  82. Smiraglia DJ , Plass C . The study of aberrant methylation in cancer via restriction landmark genomic scanning . Oncogene . 2002;21:5414–5426
  83. Feltus FA , Lee EK , Costello JF , et al.   Predicting aberrant CpG island methylation . Proc Natl Acad Sci U S A . 2003;100:12253–12258
  84. Labrador M , Corces VG . Setting the boundaries of chromatin domains and nuclear organization . Cell . 2002;111:151–154
  85. West AG , Gaszner M , Felsenfeld G . Insulators (Many functions, many mechanisms) . Genes Dev . 2002;16:271–288
  86. Song JZ , Stirzaker C , Harrison J , et al.   Hypermethylation trigger of the glutathione-S-transferase gene (GSTP1) in prostate cancer cells . Oncogene . 2002;21:1048–1061
  87. Neuland CY , Blattner WA , Mann DL , et al.   Familial chronic lymphocytic leukemia . J Natl Cancer Inst . 1983;71:1143–1150
  88. Lynch HT , Weisenburger DD , Quinn-Laquer B , et al.   Hereditary chronic lymphocytic leukemia (An extended family study and literature review) . Am J Med Genet . 2002;115:113–117
  89. Goldin LR , Pfeiffer RM , Li X , et al.   Familial risk of lymphoproliferative tumors in families of patients with chronic lymphocytic leukemia (Results from the Swedish Family-Cancer Database) . Blood . 2004;104:1850–1854
  90. Calin GA , Trapasso F , Shimizu M , et al.   Familial cancer associated with a polymorphism in ARLTS1 . N Engl J Med . 2005;352:1667–1676
  91. Caligaris-Cappio F . What are we learning from familial chronic lymphocytic leukemia? . Leuk Res . 2002;26:779–780
  92. Kn H , Bassal S , Tikellis C , et al.   Expression analysis of the epigenetic methyltransferases and methyl-CpG binding protein families in the normal B-cell and B-cell chronic lymphocytic leukemia (CLL) . Cancer Biol Ther . 2004;3:989–994
  93. Brenner C , Deplus R , Didelot C , et al.   Myc represses transcription through recruitment of DNA methyltransferase corepressor . EMBO J . 2005;24:336–346
  94. Nagy B , Lundan T , Larramendy ML , et al.   Abnormal expression of apoptosis-related genes in haematological malignancies (Overexpression of MYC is poor prognostic sign in mantle cell lymphoma) . Br J Haematol . 2003;120:434–441
  95. Esteve PO , Chin HG , Pradhan S . Human maintenance DNA (cytosine-5)-methyltransferase and p53 modulate expression of p53-repressed promoters . Proc Natl Acad Sci U S A . 2005;102:1000–1005
  96. Hamblin TJ , Davis Z , Gardiner A , et al.   Unmutated Ig V(H) genes are associated with a more aggressive form of chronic lymphocytic leukemia . Blood . 1999;94:1848–1854
  97. Geisler CH , Philip P , Christensen BE , et al.   In B-cell chronic lymphocytic leukaemia chromosome 17 abnormalities and not trisomy 12 are the single most important cytogenetic abnormalities for the prognosis (A cytogenetic and immunophenotypic study of 480 unselected newly diagnosed patients) . Leuk Res . 1997;21:1011–1023
  98. Dohner H , Fischer K , Bentz M , et al.   p53 gene deletion predicts for poor survival and non-response to therapy with purine analogs in chronic B-cell leukemias . Blood . 1995;85:1580–1589
  99. Lin K , Sherrington PD , Dennis M , et al.   Relationship between p53 dysfunction, CD38 expression, and IgV(H) mutation in chronic lymphocytic leukemia . Blood . 2002;100:1404–1409
  100. Crespo M , Bosch F , Villamor N , et al.   ZAP-70 expression as a surrogate for immunoglobulin-variable-region mutations in chronic lymphocytic leukemia . N Engl J Med . 2003;348:1764–1775
  101. Raval A , Lucas DM , Matkovic JJ , et al.   TWIST2 demonstrates differential methylation in immunoglobulin variable heavy chain mutated and unmutated chronic lymphocytic leukemia . J Clin Oncol . 2005;23:3877–3885
  102. Maestro R , Dei Tos AP , Hamamori Y , et al.   Twist is a potential oncogene that inhibits apoptosis . Genes Dev . 1999;13:2207–2217
  103. Lamy A , Sesboue R , Bourguignon J , et al.   Aberrant methylation of the CDKN2a/p16INK4a gene promoter region in preinvasive bronchial lesions (A prospective study in high-risk patients without invasive cancer) . Int J Cancer . 2002;100:189–193
  104. Insinga A , Monestiroli S , Ronzoni S , et al.   Inhibitors of histone deacetylases induce tumor-selective apoptosis through activation of the death receptor pathway . Nat Med . 2005;11:71–76
  105. Bannerji R , Byrd JC . Update on the biology of chronic lymphocytic leukemia . Curr Opin Oncol . 2000;12:22–29
  106. Genini D , Adachi S , Chao Q , et al.   Deoxyadenosine analogs induce programmed cell death in chronic lymphocytic leukemia cells by damaging the DNA and by directly affecting the mitochondria . Blood . 2000;96:3537–3543
  107. Byrd JC , Kitada S , Flinn IW , et al.   The mechanism of tumor cell clearance by rituximab in vivo in patients with B-cell chronic lymphocytic leukemia (Evidence of caspase activation and apoptosis induction) . Blood . 2002;99:1038–1043
  108. Byrd JC , Shinn C , Ravi R , et al.   Depsipeptide (FR901228) (A novel therapeutic agent with selective, in vitro activity against human B-cell chronic lymphocytic leukemia cells) . Blood . 1999;94:1401–1408
  109. Aron JL , Parthun MR , Marcucci G , et al.   Depsipeptide (FR901228) induces histone acetylation and inhibition of histone deacetylase in chronic lymphocytic leukemia cells concurrent with activation of caspase 8-mediated apoptosis and down-regulation of c-FLIP protein . Blood . 2003;102:652–658
  110. Lucas DM , Davis ME , Parthun MR , et al.   The histone deacetylase inhibitor MS-275 induces caspase-dependent apoptosis in B-cell chronic lymphocytic leukemia cells . Leukemia . 2004;18:1207–1214
  111. Zhang L , Freitas MA , Wickham J , et al.   Differential expression of histone post-translational modifications in acute myeloid and chronic lymphocytic leukemia determined by high-pressure liquid chromatography and mass spectrometry . J Am Soc Mass Spectrom . 2004;15:77–86
  112. Byrd JC , Marcucci G , Parthun MR , et al.   A phase 1 and pharmacodynamic study of depsipeptide (FK228) in chronic lymphocytic leukemia and acute myeloid leukemia . Blood . 2005;105:959–967
  113. Yang X , Phillips DL , Ferguson AT , et al.   Synergistic activation of functional estrogen receptor (ER)-alpha by DNA methyltransferase and histone deacetylase inhibition in human ER-alpha-negative breast cancer cells . Cancer Res . 2001;61:7025–7059
  114. Daskalakis M , Nguyen TT , Nguyen C , et al.   Demethylation of a hypermethylated P15/INK4B gene in patients with myelodysplastic syndrome by 5-Aza-2′-deoxycytidine (decitabine) treatment . Blood . 2002;100:2957–2964
  115. Sigalotti L , Altomonte M , Colizzi F , et al.   5-Aza-2′-deoxycytidine (decitabine) treatment of hematopoietic malignancies (A multimechanism therapeutic approach?) . Blood . 2003;101:4644–4646
  116. Lubbert M . DNA methylation inhibitors in the treatment of leukemias, myelodysplastic syndromes and hemoglobinopathies (Clinical results and possible mechanisms of action) . Curr Top Microbiol Immunol . 2000;249:135–164
  117. Issa JP , Garcia-Manero G , Giles FJ , et al.   Phase 1 study of low-dose prolonged exposure schedules of the hypomethylating agent 5-aza-2′-deoxycytidine (decitabine) in hematopoietic malignancies . Blood . 2004;103:1635–1640
  118. Cheng JC , Yoo CB , Weisenberger DJ , et al.   Preferential response of cancer cells to zebularine . Cancer Cell . 2004;6:151–158

PII: S0093-7754(05)00505-1

doi: 10.1053/j.seminoncol.2005.12.011

Seminars in Oncology
Volume 33, Issue 2 , Pages 157-166 , April 2006

Article Tools

* Image Usage & Resolution